Stockholm - Delayed Quote SEK

Neola Medical AB (publ) (NEOLA.ST)

Compare
2.5400
0.0000
(0.00%)
At close: 4:40:46 PM GMT+1
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
625.0000
31.0000
Cost of Revenue
-9,103.0000
-8,019.0000
-8,017.0000
-8,427.0000
-1,506.0000
Gross Profit
9,103.0000
8,019.0000
8,017.0000
9,052.0000
1,537.0000
Operating Expense
19,303.0000
17,645.0000
18,402.0000
15,705.0000
8,253.0000
Operating Income
-10,200.0000
-9,626.0000
-10,385.0000
-6,653.0000
-6,716.0000
Net Non Operating Interest Income Expense
802.0000
612.0000
33.0000
--
-1.0000
Pretax Income
-9,393.0000
-9,010.0000
-10,353.0000
-6,653.0000
-6,717.0000
Net Income Common Stockholders
-9,393.0000
-9,010.0000
-10,353.0000
-6,653.0000
-6,717.0000
Diluted NI Available to Com Stockholders
-9,393.0000
-9,010.0000
-10,353.0000
-6,653.0000
-6,717.0000
Basic EPS
-0.15
-0.17
-0.40
-0.47
-0.71
Diluted EPS
-0.15
-0.17
-0.40
-0.47
-0.71
Basic Average Shares
66,613.5060
55,765.5580
26,070.5860
14,013.8570
9,522.2720
Diluted Average Shares
70,150.2340
55,765.5580
26,070.5860
14,013.8570
9,522.2720
Total Operating Income as Reported
-10,194.0000
-9,621.0000
-10,386.0000
-6,653.0000
-6,716.0000
Total Expenses
10,200.0000
9,626.0000
10,385.0000
7,278.0000
6,747.0000
Net Income from Continuing & Discontinued Operation
-9,393.0000
-9,010.0000
-10,353.0000
-6,653.0000
-6,717.0000
Normalized Income
-9,393.0000
-9,010.0000
-10,353.0000
-6,653.0000
-6,717.0000
Interest Expense
--
--
--
--
1.0000
Net Interest Income
802.0000
612.0000
33.0000
--
-1.0000
EBIT
-10,200.0000
-9,626.0000
-10,385.0000
-6,653.0000
-6,716.0000
EBITDA
-8,597.0000
-8,033.0000
-9,348.0000
-6,638.0000
-6,709.0000
Reconciled Cost of Revenue
-9,103.0000
-8,019.0000
-8,017.0000
-8,427.0000
-1,506.0000
Reconciled Depreciation
1,603.0000
1,593.0000
1,037.0000
15.0000
7.0000
Net Income from Continuing Operation Net Minority Interest
-9,393.0000
-9,010.0000
-10,353.0000
-6,653.0000
-6,717.0000
Normalized EBITDA
-8,597.0000
-8,033.0000
-9,348.0000
-6,638.0000
-6,709.0000
12/31/2020 - 10/2/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NYZ.BE Novacyt SA
0.6870
+1.48%
 
CYBQF CYBERDYNE Inc.
1.0350
0.00%
 
51KA.BE AVITA Medical Inc
8.55
-0.58%
 
61MA.F MedCap AB (publ)
50.40
-2.89%
 
8C4.F CYBERDYNE Inc.
1.0760
+0.75%
 
ABT.VI Abbott Laboratories
108.06
-1.67%
 
PHIAa.XC
 
2SE.F Sequana Medical NV
2.6400
+6.45%
 
2SE.SG Sequana Medical NV
2.6400
+6.88%
 
EPIS-B.ST Episurf Medical AB (publ)
0.1320
+3.12%